+Vote!
Chinalyst - China blogs in English (Free subscription) | 07/23/2008
Seeking Alpha had a good piece Sunday on the poor performance of China's biomedical industry when it comes to venture capital funding. The comparison is simple enough. In the U.S., biomedical projects rake in 31% of all venture capital funding. In China, only 2.4% of venture capital funding went to biomedical and/or healthcare projects in the recently released Q2 numbers. Everyone keeps waiting and...
+Vote!
Chinalyst - China blogs in English (Free subscription) | 07/23/2008
Seeking Alpha had a good piece Sunday on the poor performance of China's biomedical industry when it comes to venture capital funding. The comparison is simple enough. In the U.S., biomedical projects rake in 31% of all venture capital funding. In China, only 2.4% of venture capital funding went to biomedical and/or healthcare projects in the recently released Q2 numbers. Everyone keeps waiting and...
+Vote!
H5N1 (Free subscription) | 07/24/2008
Via Ninemsn.com in Australia: Rockeby gets orders for bird flu tests. Excerpt: Rockeby Biomed Ltd has received orders for its H5N1 bird flu tests on humans from several South East Asian, European, and North African countries, worth $242,000, the company...
+Vote!
MooreThoughts (Free subscription) | 07/23/2008
According to a link unearthed by Ben Cunningham, there is preliminary research that the effects of Alzheimers may be reversible Building on previous work by the same authors, published in BioMed Central’s Journal of Neuroinflammation, this study focuses on the effect of the anti-tumor necrosis factor-alpha (TNF-alpha) drug, etanercept, on measures of verbal ability. TNF-alpha, a critical [...]...
+Vote!
Eurekalert (Free subscription) | 07/23/2008
( BioMed Central ) Newly developed software will help to allay patients' fears about who has access to their confidential data. Research published today in the open access journal BMC Medical Informatics and Decision Making describes a computer program capable of deleting details from medical records which may identify patients, while leaving important medical information intact.
1Vote!
Physorg (Free subscription) | yesterday
... help to reduce the burden of this foremost chronic childhood disease in Europe and the US. Source: BioMed Central» Next Article in Medicine & Health - Other:
+Vote!
Business Spectator (Free subscription) | 07/24/2008
Rockeby gets orders for bird flu testsTOP News The SpectatorsAAP Rockeby Biomed Ltd has received orders for its H5N1 bird flu tests on humans from several South East Asian, European, and North African countries, worth $242,000, the company says. Rockeby chief executive Dr Sze-Wee Tan said the tests had been delivered or were about to the delivered over the next few weeks. "We are pleased to...
+Vote!
Physorg (Free subscription) | 07/24/2008
... allow the software to be adapted to other data types that may exhibit different qualities. Source: BioMed Central» Next Article in Medicine & Health - Other:
+Vote!
Business Wire (Free subscription) | 07/23/2008
MELVILLE, N.Y.--(BUSINESS WIRE)--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended June 30, 2008, after the
1Vote!
Physorg (Free subscription) | 07/23/2008
... be used to "reassure a large number of women regarding their personal breast cancer risk." Source: BioMed Central» Next Article in Medicine & Health - Cancer:
+Vote!
Science - The Post Chronicle (Free subscription) | 07/23/2008
CHICAGO (Reuters) - Alzheimer's patients given a popular rheumatoid arthritis drug showed seemingly dramatic improvements in a small study, but some doctors worried that the early findings will raise premature hopes in patients and their families.The study, reported on Sunday in the journal BioMed Central BMC Neurology, involved 12 patients who had greatly improved language recall shortly after...
+Vote!
Ph articles (Free subscription) | 07/21/2008
CHICAGO (Reuters) - Alzheimer's patients given a popular rheumatoid arthritis drug showed seemingly dramatic improvements in a small study, but some doctors worried that the early findings will raise premature hopes in patients and their families. The study, reported on Sunday in the journal BioMed Central BMC Neurology, involved 12 patients who had greatly improved language recall shortly...
+Vote!
Physorg (Free subscription) | 07/21/2008
Building on previous work by the same authors, published in BioMed Central's Journal of Neuroinflammation, this study focuses on the effect of the anti-tumor necrosis factor–alpha (TNF-alpha) drug, etanercept, on measures of verbal ability. TNF-alpha, a critical component of the brain's immune system, normally finely regulates the transmission of neural impulses in the brain. The authors hypothesize...
+Vote!
New York Post (Free subscription) | 07/21/2008
Dr. Edward Tobinick, director of the Institute for Neurological Research in LA, told the journal BioMed Central BMC Neurology that all 12 patients' language recall improved greatly after treatment with the anti-inflammatory Enbrel, or etanercept.
+Vote!
Physorg (Free subscription) | 07/18/2008
Survivors of cardiac arrest who received intensive care can expect long-term quality of life at reasonable expense to the health care system. Research published today in BioMed Central's open access journal Critical Care is the first to show that the allocation of resources to the treatment of heart attack patients is equally as justified as the treatment of other intensive care patient groups....
